Disease

Ovarian Neoplasms

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · PHASE 1 TRIAL

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

ClinicalTrials.gov

This is a Phase 1/1b/2 early-stage trial registration with no posted results; it describes planned enrollment and primary endpoints only, reflecting hypothesis-generating and dose-finding work typical of first-in-human oncology studies.

PreliminaryEli Lilly and Company Itraconazole Ovarian Neoplasms

Reported

Planned enrollment575

Study phasePhase 1a/1b/2

Phase 1a primary outcomeRecommended phase 2 dose (RP2D) of Sofe-M a…

AUG 14, 2026 · INTERVENTIONAL STUDY

Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants

ClinicalTrials.gov

This is a study registration for a planned interventional feasibility trial with no results posted; it describes design and enrollment targets only, not outcomes or efficacy data.

PreliminaryGalleri Multi-Cancer Early Detection (MCED) Blood Test Ovarian Neoplasms NCT07764744

Reported

Estimated enrollment70

Primary outcome (Cohort A)Feasibility of Galleri testing in BRCA1/2 s…

Primary outcome (Cohort B)Feasibility of annual Galleri testing in ST…